Stephen K L Chia

12PUBLICATIONS
80CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersMolecular targetsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 16, 2026
Breast Cancer Follow-Up and Surveillance After Primary Treatment: ASCO Guideline Update.

|Mar 19, 2026
Correction to: A Canadian real‑world, multi‑center, prospective, observational study assessing the treatment duration, the treatment sequence, and the overall survival for patients treated with endocrine therapy ± targeted therapy in HR + HER2‑negative advanced breast cancer.

Catherine Doyle, Ana Elisa Lohmann, Nayyer Iqbal

|Aug 29, 2025
Matching-adjusted indirect comparison of ribociclib + nonsteroidal aromatase inhibitor versus abemaciclib + endocrine therapy in hormone receptor-positive/HER2-negative early breast cancer.

Stephen Chia, Jie Li, Fei Ma

|Feb 28, 2025
Health-Related Quality of Life in Patients with HR+/HER2- Early Breast Cancer Treated with Ribociclib Plus a Nonsteroidal Aromatase Inhibitor: Results from the NATALEE Trial.

Peter A Fasching, Dennis Slamon, Zbigniew Nowecki

|Jan 23, 2025
A Canadian real-world, multi-center, prospective, observational study assessing the treatment duration, the treatment sequence, and the overall survival for patients treated with endocrine therapy ± targeted therapy in HR + HER2-negative advanced breast cancer.

Catherine Doyle, Ana Elisa Lohmann, Nayyer Iqbal

|Dec 05, 2024
Clonal Hematopoiesis of Indeterminate Potential and its Association with Treatment Outcomes and Adverse Events in Patients with Solid Tumors.

Tharani Krishnan, Joao Paulo Solar Vasconcelos, Emma Titmuss

Pageof 2

Frequent Collaborators

2 joint publications

Charles E Geyer

2 joint publications

Norman Wolmark

2 joint publications

Janice M Walshe

2 joint publications

Louis Fehrenbacher